Because isocitrate dehydrogenase (IDH) glioma mutants showed a better prognosis compared to IDH-wildtype glioma patients, in the astrocytic brain tumour subgroup we also analyzed Nogo-A, MAG, and OMgp levels depending on the IDH1 gene mutation. Here, IDH3A is linked to central nervous system cancer.